Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Martin Hodge"'
Autor:
Jie Zhao, Tin Min Htut, Xinshou Ouyang, Hongxing Li, Adedayo Hanidu, Rosemarie Sellati, Jay C. Unkeless, Jun Li, Shu Zhang, Jianfei Yang, Huabao Xiong, Xiang Li, Adrian T. Ting, Mark E. Labadia, Martin Hodge, Huiping Jiang, Min Yang, Lloyd Mayer
Publikováno v:
European journal of immunology. 38(5)
Epstein-Barr virus-induced gene 3 (EBI3) associates with p28 to form IL-27 and with IL-12p35 to form IL-35. IL-27Ralpha(-/-) mice studies indicate that IL-27 negatively regulates Th17 cell differentiation. However, no EBI3, p28 or p35-deficiency stud
Autor:
Jianfei Yang, Min Yang, Tin Min Htut, Adedayo Hanidu, Xiang Li, Sosemarie Sellati, Huiping Jiang, Shu Zhang, Hongxing Li, Adrian T Ting, Lloyd Mayer, Jay C Unkeless, Mark E Labadia, Martin Hodge, Jun Li, Huabao Xiong
Publikováno v:
The Journal of Immunology. 178:S177-S177
The product of the Epstein-Barr virus-induced gene 3 (EBI3) associates with p28, an IL-12p35-related protein, to form IL-27. EBI3 also associates with IL-12p35 to form a distinct heterodimer. The function of EBI3 in innate as well as adaptive immunit
Autor:
Cooles, Faye, Tarn, Jessica, Lendrem, Dennis, Naamane, Najib, Lin, Chung Ma, Millar, Ben, Maney, Nicola, Anderson, Amy, Thalayasingam, Nishanthi, Diboll, Julie, Bondet, Vincent, Duffy, Darragh, Barnes, Michael, Smith, Graham, Ng, Sandra, Watson, David, Henkin, Rafael, Cope, Andrew, Reynard, Louise, Pratt, Arthur, Isaacs, John
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, In press, ⟨10.1136/annrheumdis-2022-222370⟩
Cooles, F A H, Tarn, J, Lendrem, D W, Naamane, N, Lin, C M A, Millar, B, Maney, N J, Anderson, A E, Thalayasingam, N, Diboll, J, Bondet, V, Duffy, D, Barnes, M R, Smith, G R, Ng, S, Watson, D, Henkin, R, Cope, A P, Reynard, L N, Pratt, A G & Isaacs, J D 2022, ' Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming ', Annals of the rheumatic diseases, vol. 81, no. 9, heartjnl-2022-222370, pp. 1214-1223 . https://doi.org/10.1136/annrheumdis-2022-222370
Ann Rheum Dis
Annals of the Rheumatic Diseases, In press, ⟨10.1136/annrheumdis-2022-222370⟩
Cooles, F A H, Tarn, J, Lendrem, D W, Naamane, N, Lin, C M A, Millar, B, Maney, N J, Anderson, A E, Thalayasingam, N, Diboll, J, Bondet, V, Duffy, D, Barnes, M R, Smith, G R, Ng, S, Watson, D, Henkin, R, Cope, A P, Reynard, L N, Pratt, A G & Isaacs, J D 2022, ' Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming ', Annals of the rheumatic diseases, vol. 81, no. 9, heartjnl-2022-222370, pp. 1214-1223 . https://doi.org/10.1136/annrheumdis-2022-222370
Ann Rheum Dis
ObjectivesAn interferon (IFN) gene signature (IGS) is present in approximately 50% of early, treatment naive rheumatoid arthritis (eRA) patients where it has been shown to negatively impact initial response to treatment. We wished to validate this ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ecfeba33e2085ceadcfd3a0dc4f6ae0
https://hal.science/hal-03699421/file/annrheumdis-2022-222370.full.pdf
https://hal.science/hal-03699421/file/annrheumdis-2022-222370.full.pdf